Osaic Holdings’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
Other funds holding TRDA
BBA
Osaic Holdings's TRDA Position: Q3 2026 in Review
Osaic Holdings held its Entrada Therapeutics (TRDA) position steady in Q3 2026 at 195 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #7478.
Osaic Holdings first reported a position in TRDA in Q4 2021 and has held it in 16 quarters since. The position peaked at $7.04K in Q4 2024. 132 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.
- Osaic Holdings held 195 shares of Entrada Therapeutics worth $1.22K as of Q3 2026.
- Osaic Holdings left its Entrada Therapeutics share count unchanged in Q3 2026.
- Entrada Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7478 holding.
- Osaic Holdings first reported a position in Entrada Therapeutics in Q4 2021 and has held it in 16 quarters since.
- Osaic Holdings's Entrada Therapeutics position peaked at $7.04K in Q4 2024.
- 132 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.